NL-OMON29562已完成不适用
Safety profile and pharmacokinetics of a synthetic cannabinoid (JWH-018)
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 55
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Used cannabis between 2 times a month and 2 times a week during the previous year
- •Age between 18 and 40 years
排除标准
- •History of drug abuse (other than the use of cannabis) or addiction (determined by the medical questionnaire, drug questionnaire and medical examination)
- •Experience with synthetic cannabis
研究者
相似试验
已完成
不适用
Safety profile and pharmacokinetics of a synthetic cannabinoid (JHW-018)NL-OMON46849niversiteit Maastricht55
已完成
1 期
Safety and pharmacokinetics study of standardized extract of Centella asiatica (ECa233) capsule in Thai healthy volunteers/AECa 233,Pharmacokinetics,Safety,Phase ITCTR20171107002Department of Thai traditional and alternative medicine, Ministry of Public Health12
进行中（未招募）
不适用
Pharmacokinetics, pharmacodynamics and safety of a new Leuprolide acetate 22.5 mg depot formulation, when given as palliative treatment to prostate cancer patientsMedDRA version: 8.1Level: LLTClassification code 10007113Term: Cancer of prostateProstate cancerEUCTR2006-005964-24-GBItalfarmaco S.p.A.20
尚未招募
不适用
Clofazimine and moxifloxacin PK, safety, and AccepTAbiLitY for paediatric TB treatment (CATALYST)TuberculosisPACTR202012756409365Stellenbosch University36
尚未招募
2 期
IVERSAL2: Pharmacokinetics safety and acceptability of DRV/r for children living with HIVHIV/AIDSPACTR202405769820746Fondazione Penta ETS50